Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
OVX836 + GC FLU
- Development stage
- Unknown
- Lead developer
- Osivax
- Modality
- Nanoparticles → Drug Delivery Systems, Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
OVX836 + GC FLU is a next-generation combination influenza vaccine candidate being co-developed by Osivax and GC Biopharma. It combines OVX836, a proprietary broad-spectrum influenza A vaccine candidate based on a recombinant self-assembling nucleoprotein (NP) nanoparticle, with GC FLU, a standard-dose inactivated seasonal influenza vaccine. The combination is designed to elicit both T-cell immune responses against the highly conserved NP antigen and antibody responses against the hemagglutinin (HA) surface antigen. This dual mechanism aims to provide broader and more durable protection against seasonal and potentially pandemic influenza strains compared to traditional vaccines.
- Other names
- OVX836 + GC FLU
02
Targets
HA (Hemagglutinin)NP (Taï Forest ebolavirus nucleoprotein)
Beyond the preview
Go deeper on OVX836 + GC FLU.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on OVX836 + GC FLU.